Robert A Casero

Professor

1980 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert A Casero is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy

Affronti, H. C., Rowsam, A. M., Pellerite, A. J., Rosario, S. R., Long, M. D., Jacobi, J. J., Bianchi-Smiraglia, A., Boerlin, C. S., Gillard, B. M., Karasik, E., Foster, B. A., Moser, M., Wilton, J. H., Attwood, K., Nikiforov, M. A., Azabdaftari, G., Pili, R., Phillips, J. G., Casero, R. A. & Smiraglia, D. J., Dec 1 2020, In : Nature communications. 11, 1, 52.

Research output: Contribution to journalArticle

Open Access
  • DFMO and 5-azacytidine increase M1 macrophages in the tumor microenvironment of murine ovarian cancer

    Travers, M., Brown, S. M., Dunworth, M., Holbert, C. E., Wiehagen, K. R., Bachman, K. E., Foley, J. R., Stone, M. L., Baylin, S. B., Casero, R. A. & Zahnow, C., Jan 1 2019, In : Cancer Research. 79, 13, p. 3445-3454 10 p.

    Research output: Contribution to journalArticle

  • Dual inhibitors of LSD1 and spermine oxidase

    Holshouser, S., Dunworth, M., Murray Stewart, T., Peterson, Y. K., Burger, P., Kirkpatrick, J., Chen, H. H., Casero, R. A. & Woster, P. M., Jan 1 2019, In : MedChemComm. 10, 5, p. 778-790 13 p.

    Research output: Contribution to journalArticle

  • Elevation of cellular Mg2+ levels by the Mg2+ transporter, Alr1, supports growth of polyamine-deficient Saccharomyces cerevisiae cells

    Hanner, A. S., Dunworth, M., Casero, R. A., MacDiarmid, C. W. & Park, M. H., Jan 1 2019, In : Journal of Biological Chemistry. 294, 45, p. 17131-17142 12 p.

    Research output: Contribution to journalArticle

  • Corrigendum to “Structure–activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures” [Bioorg. Med. Chem. 23 (2015) 1601–1612]

    Nowotarski, S. L., Pachaiyappan, B., Holshouser, S. L., Kutz, C. J., Li, Y., Huang, Y., Sharma, S. K., Casero, R. A. & Woster, P. M., Jan 1 2018, (Accepted/In press) In : Bioorganic and Medicinal Chemistry.

    Research output: Contribution to journalArticle